Is Apolipoprotein B and Small, Dense low density lipoprotein a better marker of cardiovascular risk?

Journal Title: International Journal of Biomedical Research - Year 2015, Vol 6, Issue 10

Abstract

The association between low density lipoprotein cholesterol and cardiovascular risk is well established. However, the measurement of the cholesterol content of this lipoprotein incompletely accounts for the risk of cardiovascular disease. As part of its limitations, LDL cholesterol concentration does not precisely count the number of LDL particles, but Apo B does. The levels of Apolipoprotein B and small dense low density lipoprotein have been shown to be associated with risk of cardiovascular disease.. There is one Apo B per LDL particle, hence, LDL-Apo B accurately defines LDL particle number. Also, the ratio of cholesterol to Apo B differs from person to person, thereby explaining why LDL-cholesterol level does not necessarily indicate LDL particle number. Furthermore, Apo B reflects the concentration of potentially atherogenic particles i.e. the total Apo B level is a measure of the total number of lipoprotein particles in LDL, IDL and VLDL (non-HDL cholesterol). This implies that if most Apo B-containing lipoproteins in each fraction are atherogenic, the total concentration of Apo B will indicate cardiovascular risk better than LDL cholesterol level does. A predominance of small, dense, low-density lipoprotein cholesterol particles has been associated with a 3-fold or even greater risk of coronary heart disease in a collection of cross-sectional studies. Recent prospective evidence describes small, dense, low-density lipoprotein cholesterol as predictive of coronary heart disease as most of the traditional risk factors like smoking and elevated blood pressure. Cardiovascular risk is more directly related to the number and sizes of circulating atherogenic particles than to the concentration of cholesterol in these particles, therefore, adopting the traditional lipid profile (Triglyceride, HDL, LDL, total cholesterol etc.) will result in an underestimation of the true atherogenic burden as well as serve as a poor assessment of cardiovascular risk in individuals.

Authors and Affiliations

Ifeoluwa Silvanus Abiodun

Keywords

Related Articles

Prediction of peak expiratory flow rate from armspan in healthy children aged 8 to 12 years

Peak expiratory flow rate (PEFR) was measured in 400 normal healthy school going children in the age group of 8 to 12 years of Lucknow city. It was observed that there was a gradual, parallel progressive increase in the...

Routine Cytogenetic Analysis of Chromosome Abnormalities in Acute Lymphoblastic Leukemia

Acute lymphoblastic leukemia (ALL) is the most common cancer in children. Acquired chromosomal and genetic abnormalities have been used to define distinct biological and clinical subtypes of ALL. These aberrations have b...

Water, hygiene and sanitation practices amongst medical students in Moi University Eldoret, Kenya

Background: Hand washing with soap and water is one of the most effective and inexpensive means of preventing infections. Rates of hand washing are low worldwide even amongst health care workers who should know about its...

Antibiotic resistance pattern of enterococcal isolates from patients with urinary tract infection

Background: Enterococci are the most common cause of healthcare associated urinary tract infections. The frequency of isolation of Enterococci from urinary tract of hospitalized patients has risen. Enterococcus is consid...

MHC-Ig Dimers: The next Frontier in Transplantation Immunology

Organ transplantation offers hope to a variety of patients with terminal functioning organs and tissues. This is currently made possible by administration of general immunosuppressive drugs. To date, inducing tolerance t...

Download PDF file
  • EP ID EP419991
  • DOI 10.7439/ijbr.v6i10.2638
  • Views 86
  • Downloads 0

How To Cite

Ifeoluwa Silvanus Abiodun (2015). Is Apolipoprotein B and Small, Dense low density lipoprotein a better marker of cardiovascular risk?. International Journal of Biomedical Research, 6(10), 775-779. https://europub.co.uk/articles/-A-419991